Hongxia Li
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8+ T cells in checkpoint inhibitor pneumonitis.
Journal: Med (New York, N.Y.)
Published: November 17, 2025
Advances in Microbial Remediation of Heavy Metal-Contaminated Soils: Mechanisms, Synergistic Technologies, Field Applications and Future Perspectives.
Journal: Toxics
Published: November 03, 2025
Photothermal-Driven Subcellular Calcium Ion Translocation and Mitochondrial Dysfunction for Augmented Tumor Therapy.
Journal: Advanced healthcare materials
Published: September 15, 2025
A self-controlled study on endotracheal tube cuff pressure management modes
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: August 15, 2025
Real-world evidence for immunotherapy in the first-line or subsequent-line setting in extensive-stage small-cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: July 22, 2025
Contezolid for the Super-Elderly: Balancing Efficacy and Safety Through Pharmacokinetic Insights.
Journal: Clinical interventions in aging
Published: July 16, 2025
Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients.
Journal: Journal of translational medicine
Published: May 28, 2025
Metal-organic frameworks activate the cGAS-STING pathway for cancer immunotherapy.
Journal: Journal of nanobiotechnology
Published: April 29, 2025
Analysis of the Correlation between Immune Cell Subsets in Bronchoalveolar Lavage Fluid and the Efficacy of First-line Use of Immunotherapy in Advanced Non-small Cell Lung Cancer: A Case-control Study
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: February 18, 2025
Optimal dosing regimens for linezolid in older patients.
Journal: Intensive care medicine
Published: February 14, 2025
EGFR-TKI monotherapy versus combination therapy as first-line treatment for EGFR-mutant NSCLC with brain metastases: a real-world comparison analysis.
Journal: BMC cancer
Published: November 17, 2024
Last Updated: 09/26/2026